Bio Path Holdings Inc (BPTH)

[Gpheart2016]

SJ, you might be right that BP-1002 does not matter but a second drug with positive phase 1 results would certainly boost the potential of this company. A bigger pipeline like BioMarin produces many more buyers. I cannot see why a phase 1 study would slow down the AML phase 2 study but of course it does require more funding and that may be the reason PN is dragging his feet.
Let's hope yesterday's selling stops and this thing starts to turn around.